|
84
|
385
|
4nqaB |
Crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna |
|
97
|
320
|
4iqrA |
Multi-domain organization of the hnf4alpha nuclear receptor complex on dna |
|
111
|
371
|
3e00D |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide |
|
102
|
370
|
3dzyD |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide |
|
104
|
370
|
3dzuD |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide |
|
79
|
324
|
3e00A |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide |
|
91
|
324
|
3dzuA |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide |
|
83
|
324
|
3dzyA |
Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide |
|
94
|
242
|
3up0A |
Nuclear receptor daf-12 from hookworm ancylostoma ceylanicum in complex with (25s)-delta7-dafachronic acid |
|
91
|
269
|
3s9sA |
Ligand binding domain of ppargamma complexed with a benzimidazole partial agonist |
|
93
|
225
|
5m96A |
Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt inverse agonists |
|
88
|
244
|
5lwpA |
Discovery of phenoxyindazoles and phenylthioindazoles as rorg inverse agonists |
|
94
|
299
|
5lgaA |
Structural analysis and biological activities of bxl0124, a gemini analog of vitamin d |
|
99
|
248
|
5l7eA |
Mcr in complex with ligand |
|
95
|
248
|
5l7gA |
Mcr in complex with ligand |
|
79
|
244
|
5krkA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 4,4'-((5-bromo-2,3-dihydro-1h-inden-1-ylidene)methylene)diphenol |
|
87
|
243
|
5kroA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the methyl(phenyl)amino-substituted estrogen, (8r,9s,13s,14s,17s)-13-methyl-17-(methyl(phenyl)amino)-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-ol |
|
86
|
244
|
5krhA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 16-benzylidene estrone |
|
94
|
245
|
5krcA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with zearalenone |
|
90
|
246
|
5kr9A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with coumestrol |
|
95
|
260
|
5kyjA |
Brain penetrant liver x receptor (lxr) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core |
|
91
|
244
|
5krlA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the a-cd ring estrogen, (1s,7as)-5-(2-chloro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-ol |
|
84
|
245
|
5krjA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an a-naphthyl substituted obhs derivative |
|
89
|
244
|
5kriA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 16b-benzyl 17b-estradiol |
|
92
|
237
|
5l11A |
Human liver receptor homologue-1 (lrh-1) bound to rjw100 and a fragment of tif-2 |
|
88
|
245
|
5krmA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the a-cd ring estrogen, (1s,7as)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-ol |
|
82
|
243
|
5kcuA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, alpha-naphthyl obhs-n derivative |
|
85
|
247
|
5kceA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-methyl, 2-chlorobenzyl obhs-n derivative |
|
92
|
244
|
5kcdA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-methyl substituted obhs-n derivative |
|
90
|
247
|
5kcfA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, 4-methoxybenzyl obhs-n derivative |
|
99
|
251
|
5jjmB |
Crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide |
|
88
|
244
|
5kd9A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-trifluoroethyl 4-chlorobenzyl obhs-n derivative |
|
92
|
235
|
5k13A |
Crystal structure of the rar alpha ligand-binding domain in complex with an antagonist |
|
87
|
245
|
5kcwA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-trifluoroethyl obhs-n derivative |
|
81
|
244
|
5kccA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with oxabicyclic heptene sulfonamide (obhs-n) |
|
98
|
252
|
5jjmA |
Crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide |
|
91
|
246
|
5kctA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, 4-chlorobenzyl obhs-n derivative |
|
80
|
240
|
5jy3A |
Crystal structure of lxrbeta (nuclear receptor subfamily 1, group h, member 2) complexed with bms-852927 |
|
84
|
219
|
5ixkA |
Rorgamma in complex with inverse agonist bio399. |
|
90
|
228
|
5iawA |
Novel natural fxr modulator with a unique binding mode |
|
102
|
260
|
5i4vA |
Discovery of novel, orally efficacious liver x receptor (lxr) beta agonists |
|
85
|
243
|
5hyrA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with stapled peptide src2-sp2 and estradiol |
|
96
|
267
|
5hykA |
Crystal structure of the complex pparalpha/al26-29 |
|
95
|
268
|
5hzcA |
Crystal structure of the complex ppargamma/al26-29 |
|
72
|
250
|
5hjpA |
Identification of lxrbeta selective agonists for the treatment of alzheimer's disease |
|
89
|
250
|
5h1eA |
Interaction between vitamin d receptor and coactivator peptide src2-3 |
|
98
|
261
|
5hjpB |
Identification of lxrbeta selective agonists for the treatment of alzheimer's disease |
|
98
|
272
|
4ci5A |
Structural basis for gl479 a dual peroxisome proliferator-activated receptor gamma agonist |
|
93
|
241
|
5c4tA |
Identification of a novel allosteric binding site for rorgt inhibitors |
|
92
|
241
|
5c4oA |
Identification of a novel allosteric binding site for rorgt inhibitors |
